retatrutide clinical trials results weight loss produces up to 30.3% in Phase 3 trial ⭐️topline results from TRIUMPH-1, a

6+ months: Long-term benefits continue, with sustained weight management when lifestyle habits are maintained

The most frequently occurring events are gastrointestinal disorders, such as nausea, diarrhea, vomiting, abdominal pain, and so on (11)

It slows down how fast your stomach empties, which means sugar absorption into your blood slows down too

Patients with an active and fulfilling sex life often find their mental health improving, which can also positively influence their physical health

Whilst emerging evidence suggests potential mood benefits, GLP-1 agonists are not without adverse effects, and mental health monitoring remains important during treatment

Heres the month-by-month breakdown based on aggregate data from 338 Phase 2 trial participants: This timeline is remarkably consistent across patients